瑞士诺华的地拉罗司如何购买

Headquartered in Basel, Switzerland, Novartis is a leading multinational company in the global pharmaceutical and consumer healthcare industries. It is committed to researching, developing and promoting innovative products to help humans cure diseases, alleviate pain and improve quality of life. Novartis produces the only oral iron chelator, which was approved in the United States in 2005 for the treatment of chronic iron overload in patients 2 years and older due to blood transfusions.

A study analyzed the iron-removing efficacy of deferasirox in 64 AA patients with iron overload after 12 months of treatment. The results showed that the median serum ferritin (SF) level increased from 4924 (2) at baseline. 718~6765) μg/L (64 cases) dropped to 3036 (1474~5551) μg/L (23 cases), a decrease of 38%. The median reduction in SF was 651 (126~2125) μg/L; 23 cases completed 12 months of treatment. The median SF level of patients dropped from the baseline of 5271 (3420~8278) μg/L to 3036 (1474~5551) μg/L, a decrease of 42%, and the median SF reduction was 1167 (580~4806) μg/L.

Deferasirox from Switzerland's Novartis can effectively treat patients with chronic iron overload caused by blood transfusions. How can patients buy it?

In 2010, Novartis of Switzerland was approved for marketing in my country, and patients can buy it in some domestic hospitals with prescriptions issued by doctors. However, the price of domestic original drugs is relatively high, and many patients cannot afford it. Deferasirox is currently on the market in more than 80 countries. We have learned that the cheaper version is 400mg*30 tablets with a price of about 420$. It is also produced by Novartis. If you have purchase needs, please consult the Medical Partner Travel Overseas Medical Consulting Service Company for specific information.

Recommended related hot articles: /newsDetail/94006.html

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.